Key result
Emery-Dreifuss muscular dystrophy requires rigorous cardiopulmonary assessment and avoidance of succinylcholine perioperatively.
Why the study?
Emery-Dreifuss Muscular Dystrophy presents special perioperative challenges due to multisystem involvement including cardiac abnormalities, requiring tailored anaesthetic management.
This narrative review provides a comprehensive overview of perioperative anaesthetic management strategies for high-risk patients with Emery-Dreifuss Muscular Dystrophy, emphasizing rigorous cardiac evaluation and monitoring.
Answers are grounded in this paper and cite their sources.
Intensive cardiac monitoring and tailored anesthesia may be prudent in Emery-Dreifuss muscular dystrophy; leaves open need for prospective validation before routine adoption.
Emery-Dreifuss Muscular Dystrophy (EDMD) is a very rare but also clinically important laminopathy that is accompanied by early contractures, weakness of the humeroperoneal muscles and progressive cardiac involvement such as conduction abnormalities, atrial arrhythmias, and dilated cardiomyopathy. These multisystem characteristics present special perioperative problems in EDMD, and thus, EDMD is a high-risk condition for anaesthesiologists. This is a narrative review summarising the existing evidence, also highlighting the overall picture of perioperative considerations in EDMD in the light of preoperative optimisation, intraoperative monitoring, anaesthetic pharmacology and postoperative care. Preoperative evaluation of EDMD requires meticulous cardiac assessment with the help of ECG, echocardiography, Holter monitoring, as well as pacemaker/Implantable CardioverterDefibrillator (ICD) interrogation, alongside respiratory evaluation, which proves beneficial for restrictive physiology. Intraoperatively, it is necessary to have rhythm surveillance, invasive haemodynamic surveillance, quantitative neuromuscular surveillance, and the presence of external pacing. Succinylcholine should not be used because of the risks of hyperkalemia and rhabdomyolysis, and the non depolarising agents also require careful titration. Total Intravenous Anaesthesia (TIVA) may be preferred over volatile anaesthetic agents in selected patients, and multimodal analgesia, which is safe. Despite the advantages of the regional and neuraxial practices like opioid sparing and cardiac stability, their implementation needs a thorough selection of patients and cardiac preparedness. In the postoperative period, the EDMD patients should be monitored at the ICU level to identify the arrhythmias, respiratory dysfunction, and delayed neuromuscular recovery. The present review highlights the need for adequately standardised protocols and future research to improve perioperative safety related to the management of EDMD patients.
No takes yet. Share an insight, caveat, or question.
Gummalla et al. (2026) conducted a review in Emery-Dreifuss Muscular Dystrophy (EDMD). Perioperative anaesthetic management was evaluated. Perioperative management of Emery-Dreifuss Muscular Dystrophy requires meticulous cardiac and respiratory assessment, strict intraoperative monitoring, and avoidance of succinylcholine.
Synapse has enriched 10 related papers. Consider them for comparative context: